Clinical trials sponsored by Suzhou BlueHorse Therapeutics Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Suzhou BlueHorse Therapeutics Co., Ltd.

• A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
  NCT05366478 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer
  NCT07444437 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• A Phase II Trial of LM103 in Advanced Melanoma
  NCT07310784 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 16 locations

Common questions

How many trials is Suzhou BlueHorse Therapeutics Co., Ltd. recruiting for?

Suzhou BlueHorse Therapeutics Co., Ltd. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.